OR WAIT null SECS
May 12, 2014
The ionHP biodecontamination hydrogen peroxide-based sterilization technology is designed for use in aseptic enclosures.
April 07, 2014
Dalton Pharma completes its $2.5 million expansion in Toronto for sterile and aseptic filling capabilities.
February 02, 2014
PDA works with FDA to create pharmaceutical quality metrics.
November 12, 2013
Progress in delivery science, manufacturing technologies, and commercialization are playing critical roles in advancing the development of complex parenteral drug formulations for new drug substances having a variety of formulation challenges
October 09, 2013
Aesica expands aseptic capabilities at its Nottingham, UK site with the acquisition of new pre-filled syringes manufacturing equipment.
August 21, 2013
RABS is a flexible barrier system that maximizes product control but minimizes operator interaction when best practices are followed.
July 23, 2013
Susan Schniepp, vice-president of quality and regulatory affairs at Allergy Laboratories and co-chair of the program planning committee for the 2013 PDA/FDA Joint Regulatory Conference, discusses quality systems and related considerations in parenteral drug manufacturing.
July 18, 2013
New cartridges designed specifically for use on high-speed filling lines increase efficiency.
July 09, 2013
Report outlines recommended practices for control and evaluation of operations.
July 02, 2013
A screening method aligned with USP 1660 guidance predicts glass delamination in primary packaging for parenterals.